Safety and effectiveness of tadalafil in pediatric patients with pulmonary arterial hypertension: a sub-group analysis based on Japan post-marketing surveillance-Reference-Cited by-同舟云学术

Safety and effectiveness of tadalafil in pediatric patients with pulmonary arterial hypertension: a sub-group analysis based on Japan post-marketing surveillance

Published:2017-07-20 Issue:12 Volume:33 Page:2241-2249
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Yamazaki Hiroyoshi¹,Kobayashi Noriko²,Taketsuna Masanori³,Tajima Koyuki⁴,Suzuki Nahoko⁵,Murakami Masahiro⁶

Affiliation:

1. Global Patient Safety Japan, Quality & Patient Safety, Eli Lilly Japan K.K., Kobe, Japan;

2. Post Marketing Study Management, Medicines Development Unit Japan, Eli Lilly Japan K. K., Kobe, Japan;

3. Statistical Sciences, Medicines Development Unit Japan, Eli Lilly Japan K.K., Kobe, Japan;

4. Post Marketing Surveillance Clinical Research Department, Nippon Shinyaku CO., Ltd, Kobe, Japan;

5. Biometrics, Medicines Development Unit Japan, Eli Lilly Japan K.K., Tokyo, Japan;

6. Medical Science, Medicines Development Unit Japan, Eli Lilly Japan K.K., Kobe, Japan

Funder

Eli Lilly Japan KK

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2017.1354832

Reference23 articles.

1. Classification of Pediatric Pulmonary Hypertensive Vascular Disease: Does it Need to Be Different from the Adult Classification?

2. Primary pulmonary hypertension

3. Japan Intractable Diseases Information Center. 2014. http://www.nanbyou.or.jp/entry/1356#p09. Accessed March 3, 2017

4. Pulmonary arterial hypertension

5. Pulmonary Arterial Hypertension

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphodiesterase 5 Inhibitor for Pediatric Pulmonary Arterial Hypertension: A Cost-Utility Analysis;Value in Health Regional Issues;2023-07

2. Pharmacotherapy for Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia: Past, Present, and Future;Pharmaceuticals;2023-03-28

3. Successful treatment of pulmonary hypertension in a neonate with bronchopulmonary dysplasia: A case report and literature review;World Journal of Clinical Cases;2022-11-16

4. Physiologically based pharmacokinetic modeling of tadalafil to inform pediatric dose selection in children with pulmonary arterial hypertension;CPT: Pharmacometrics & Systems Pharmacology;2021-12

5. Treatment of pulmonary arterial hypertension in children;Cardiovascular Diagnosis and Therapy;2021-08